Truist Securities Reiterates Hold on OrthoPediatrics, Lowers Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter has reiterated a Hold rating on OrthoPediatrics (NASDAQ:KIDS) and lowered the price target from $35 to $30.
August 08, 2024 | 12:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities analyst Richard Newitter has reiterated a Hold rating on OrthoPediatrics and lowered the price target from $35 to $30.
The lowered price target from $35 to $30 suggests a less optimistic outlook for OrthoPediatrics, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100